Obesity: which drug and when?
BACKGROUND
Obesity, with all its consequences, is audaciously confronting medical professionals and health service providers worldwide. Diet and exercise intervention is an essential part of any weight management strategy, but may not succeed in isolation. Effective approaches for routine practice are more likely to involve affordable, efficacious and well-tolerated drug therapy than the more expensive, case selective approach of bariatric surgery.


CONCLUSIONS
Advancement of pharmacotherapy is expanding the battery of available drugs; the clinician is faced with an increasingly complex therapeutic decision. Which drug to use, and when, is influenced by a range of factors, discussed here. There is a large body of high quality evidence in the literature to support the presently available drugs; however, many questions remain unanswered including duration of therapy and whether longer-term goals of improved morbidity and mortality are achievable. Clinician and patient awareness of these issues will provide a more informed therapeutic decision and ultimately improve the potential for reaching the weight management targets.
Division of Developmental Medicine, Human Nutrition Section, University of Glasgow, Royal Infirmary, Queen Elizabeth Building, Glasgow, UK. lean@clinmed.gla.ac.uk
M
M
Lean
A
A
Mullan
D019440:Anti-Obesity Agents / Q000008:administration & dosage* / Q000009:adverse effects; D050110:Bariatric Surgery / Q000191:economics; D015992:Body Mass Index; D015444:Exercise; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D015431:Weight Loss
D019440:Anti-Obesity Agents